Panitch Schwarze Belisario & Nadel LLP
Dapagliflozin crystal form and preparation method and use thereof
Disclosed are a new dapagliflozin crystal form and a preparation method and use thereof. In particular, disclosed are a crystal form E of 2-chloro-5-(β-D-glucopyranose-1-yl)-4′-ethyoxyldiphenylmethane and a preparation method therefor, and a pharmaceutical composition containing a therapeutically effective amount of the crystal form and the use thereof in treating type II diabetes.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
A C A C
A61K C07B A61P C07D
inventional additional inventional inventional
Zuyin Jun Lei Xiang Jinjia
Du Yu He Li Wang